A topological modification of ipriflavone 1, a recent antiosteoporotic drug, is described. The flavone moiety of 1 has been replaced by a xanthone one. Among the new derivatives, the 3,6‐diisopropoxyxanthone (2a) has shown significant bone resorption inhibition in in vitro and in vivo tests.
描述了最近的抗骨质疏松药物 ipriflavone 1 的拓扑修饰。1 的
黄酮部分已被
呫吨酮部分取代。在新的衍
生物中,3,6-二异丙氧基
氧杂蒽酮 (2a) 在体外和体内试验中显示出显着的骨吸收抑制作用。